Triple Negative Breast Cancer - BCL2 in Prognosis and Prediction. Review

MLA

Jan Bouchal, et al. “Triple Negative Breast Cancer - BCL2 in Prognosis and Prediction. Review.” Current Drug Targets, vol. 15, Nov. 2014, pp. 1166–75. EBSCOhost, https://doi.org/10.2174/1389450115666141106151143.

APA

Jan Bouchal, Katerina Bouchalova, Gvantsa Kharaishvili, Jana Vrbkova, Magdalena Megova, & Alice Hlobilkova. (2014). Triple Negative Breast Cancer - BCL2 in Prognosis and Prediction. Review. Current Drug Targets, 15, 1166–1175. https://doi.org/10.2174/1389450115666141106151143

Chicago

Jan Bouchal, Katerina Bouchalova, Gvantsa Kharaishvili, Jana Vrbkova, Magdalena Megova, and Alice Hlobilkova. 2014. “Triple Negative Breast Cancer - BCL2 in Prognosis and Prediction. Review.” Current Drug Targets 15 (November): 1166–75. doi:10.2174/1389450115666141106151143.